21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
24.06.2012
- Teva Pharmaceutical Industries rose more than 11% on Sunday after a U.S. court upheld Teva's patents for multiple sclerosis drug Copaxone well into 2015. Israel-based Teva, the...
24.04.2012
- Watson Pharmaceuticals aims to announce an agreement to buy Actavis for around $6 billion on Wednesday, April 25th, in a deal making it one of the world's biggest suppliers of...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
29.03.2011
- The worldwide market for copies of biotech medicines will grow to $3.7 billion by 2015, from just $243 million in 2010, as a raft of branded drugs lose patent cover, according to...
11.02.2011
- Novartis and its Sandoz unit, maker of a generic version of an anaesthetic used in lethal injections in the United States, have taken steps to try to stop the drug ending up in the...
10.02.2011
- Novartis´ generics unit Sandoz is working on eight to 10 new biosimilar molecules to cement its position as leading maker of copycat versions of pricey biotech drugs, the unit's...
01.02.2011
- U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...
